pharma · Relapsing-Remitting Multiple Sclerosis · Spinal Muscular Atrophy
Biogen
Biogen clinical programs — 21 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 225 Binney Street, Cambridge, MA 02142, US
- Employees
- 7,534
- Programs
- 31
- Drugs
- 45
- Patents
- 25
Biogen projects
21 ClinicalTrials.gov programs sponsored by Biogen.
Biogen has 21 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
105MS306
Biogen
Relapsing Remitting Multiple Sclerosis (RRMS)
1 trial -
230LE301
Biogen
Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus
1 trial -
230LE303
Biogen
systemic lupus erythematosus
1 trial -
230LE304
Biogen
systemic lupus erythematosus
1 trial -
230LE306
Biogen
Systemic lupus erythematosus
1 trial -
233AS303
Biogen
Amyotrophic Lateral Sclerosis (ALS) associated with SOD1 gene mutation
1 trial -
299AR301
Biogen
Kidney Transplant Recipients with Late Antibody-Mediated Rejection
1 trial -
299IG301
Biogen
IgA nephropathy
1 trial -
BG00012
Biogen
Relapsing-Remitting Multiple Sclerosis
1 trial -
BIIB019 (Daclizumab)
Biogen
Relapsing-Remitting Multiple Sclerosis
1 trial -
BIIB059
Biogen
1. Lupus Erythematosus, Cutaneous, Subacute 2. Chronic Cutaneous Lupus Erythematosus
1 trial -
BIIB111
Biogen
Choroideremia (CHM) X-Linked Retinitis Pigmentosa (XLRP)
1 trial -
Bardoxolone methyl
Biogen
Pulmonary Hypertension
1 trial -
Felzartamab
Biogen
Immunoglobulin A Nephropathy (IgAN)
1 trial -
Hard capsules, BIIB141
Biogen
Friedreich’s ataxia
1 trial -
Placebo
Biogen
Multiple Sclerosis, Remittent Progressive
1 trial -
SPINRAZA 28 mg, SPINRAZA 50 mg
Biogen
Spinal Muscular Atrophy
1 trial -
SPINRAZA 50 mg, SPINRAZA 28 mg
Biogen
Spinal Muscular Atrophy
1 trial -
TECFIDERA
Biogen
Relapsing-Remitting Multiple Sclerosis
1 trial -
Tofersen
Biogen
Amyotrophic Lateral Sclerosis
1 trial -
dimethyl fumarate
Biogen
Relapsing-Remitting Multiple Sclerosis
1 trial
Frequently asked questions
How many clinical projects does Biogen have?
21 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.